Gastrointestinal Microbiota Disruption and Risk of Colonization with Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients

Keyphrases

• Gastrointestinal Microbiome 100%
• Intensive Care Unit Patients 100%
• MDR-PA 100%
• Pseudomonas Aeruginosa Colonization 72%
• Piperacillin-tazobactam 27%
• Lactobacillus 18%
• Antibiotics 18%
• Opioids 18%
• Microbiota 18%
• Intensive Care Unit Admission 18%
• Odds Ratio 18%
• Clostridiales 18%
• 95% Confidence Interval 18%
• Medical Center 9%
• Enterococcus 9%
• Low Risk 9%
• Patient Characteristics 9%
• Antimicrobial Use 9%
• Group by 9%
• Protective Behavior 9%
• Gastrointestinal Tract 9%
• 3-group 9%
• Low Abundance 9%
• Negatively Associated 9%
• Relative Abundance 9%
• University of Maryland 9%
• Bacterial Taxa 9%
• Dysbiosis 9%
• Pseudomonas Aeruginosa Infection 9%
• Pathobiont 9%
• Blautia 9%
• 16S Ribosomal RNA Sequencing 9%
• Perirectal Swab 9%

Medicine and Dentistry

• Pseudomonas aeruginosa 100%
• Intensive Care Unit 100%
• Carbapenem 100%
• Microflora 100%
• Piperacillin/Tazobactam 27%
• Lactobacillus 18%
• Clostridiales 18%
• Antibiotics 18%
• Odds Ratio 18%
• Antiinfective Agent 9%
• Patient Characteristics 9%
• Gastrointestinal Tract 9%
• Enterococcus 9%
• RNA Gene 9%
• RNA 16S 9%
• Pseudomonas Infection 9%
• Gene Sequence 9%
• Dysbiosis 9%
• Blautia 9%

Immunology and Microbiology

• Intestine Flora 100%
• Pseudomonas aeruginosa 100%
• Taxon 36%
• Microflora 18%
• Lactobacillus 18%
• Clostridiales 18%
• Infectious Disease 9%
• Gastrointestinal Tract 9%
• Blautia 9%
• Enterococcus 9%
• Gene Sequence 9%
• RNA Gene 9%
• Infection 9%
• Dysbiosis 9%